speb/financial-data huggingface dataset:
Stock screener scorecard for UNFI (quarterly, report date 2026-04-30)
Altman Z-score: 1.8206744089542888 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.4849594559246664%
Earnings yield: 1.5527986371629676%
Return on net tangible assets: 5.982905982905983%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.0021074815595363%
Free cash flow margin: 0.4503940948329789%
Revenue growth: 0.5788347804202845%
Rule of 40 score: 1.0292288752532635
Market cap: 3005985536 (Mid Cap ($2B-$10B))
P/E ratio: 22.933086233333334
Debt to equity: 1.9725
Free cash flow (dilution adjusted): 36000000
Operating income: 95000000
Net income: 33000000
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 1057.HK (annual, report date 2025-12-31)
Altman Z-score: 2.001286698538237 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 14.852706843104723%
Earnings yield: 1.4383442496733412%
Return on net tangible assets: 4.752071364372339%
Capitalized R&D asset: 50958790.64956367
ROCI (R&D adjusted): 12.58513059218144%
Rosenberg metric: 0.7639172066500775
Free cash flow margin: 0.5655214813732967%
Revenue growth: 37.40830630649977%
Rule of 40 score: 37.97382778787306
Market cap: 959649794.3444729 (Small Cap ($300M-$2B))
P/E ratio: 4.770885971967037
Debt to equity: 0.05554567601596372
Free cash flow (dilution adjusted): 2867155.1385714286
Operating income: 37462323.58285715
Net income: 28735297.504285716
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2333.HK (quarterly, report date 2025-06-30)
Altman Z-score: 0.8641714277784505 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.622033918505636%
Earnings yield: 2.11949824851682%
Return on net tangible assets: 3.5365050992435547%
Capitalized R&D asset: 640819381.1331692
ROCI (R&D adjusted): 4.1682187125785175%
Rosenberg metric: 0.8533813328535084
Free cash flow margin: 30.41361445760728%
Revenue growth: 29.385389694379267%
Rule of 40 score: 59.79900415198655
Market cap: 23392956217.64331 (Large Cap ($10B-$200B))
P/E ratio: 1.9550743582393117
Debt to equity: 0.6861602505469985
Free cash flow (dilution adjusted): 2169120896.1283126
Operating income: 608904095.9539748
Net income: 639576066.6527196
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2471.T (annual, report date 2025-11-30)
Altman Z-score: 1.4545634329869863 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 8.753709198813056%
Earnings yield: 0.03492102159763252%
Return on net tangible assets: 32.710372787501235%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.198888286334057%
Free cash flow margin: 14.184179184755466%
Revenue growth: -1.4717422200464703%
Rule of 40 score: 12.712436964708996
Market cap: 21712813310.000004 (Large Cap ($10B-$200B))
P/E ratio: 15.036574314404433
Debt to equity: 2.3976871814974516
Free cash flow (dilution adjusted): 23624264.14128487
Operating income: 15478628.103404146
Net income: 9239825.953416944
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3197.T (annual, report date 2025-12-31)
Altman Z-score: 2.659489012382039 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.5690334383153%
Earnings yield: 0.024828168392991914%
Return on net tangible assets: 954.9629324546952%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.250403580063749%
Free cash flow margin: 10.859540707440733%
Revenue growth: 14.548545825085904%
Rule of 40 score: 25.40808653252664
Market cap: 764371353664.4845 (Mega Cap (>= $200B))
P/E ratio: 45.63956016625774
Debt to equity: 0.6593323985562493
Free cash flow (dilution adjusted): 317844127.613324
Operating income: 191528674.63717154
Net income: 107077552.58615178
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for 5AP.DE (annual, report date 2025-07-31)
Altman Z-score: 6.121294892769261 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 461.87290969899664%
Earnings yield: 0.5355751987502473%
Return on net tangible assets: 49.340707787263035%
Capitalized R&D asset: 3725718000
ROCI (R&D adjusted): 7.392768952075561%
Rosenberg metric: 0.44301978556427546
Free cash flow margin: 23.58293119340671%
Revenue growth: 14.873871068203051%
Rule of 40 score: 38.456802261609766
Market cap: 142615632183.90805 (Large Cap ($10B-$200B))
P/E ratio: 125.77443529756422
Debt to equity: 0.043223761566382086
Free cash flow (dilution adjusted): 2174700000
Operating income: 1242900000
Net income: 1133900000
Long score: 12 | Short score: 2
Recommendation: Long
Stock screener scorecard for AMGN (annual, report date 2025-12-31)
Altman Z-score: 1.6708946382761938 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 79.08718752721889%
Earnings yield: 3.6577962370318664%
Return on net tangible assets: -34.119759737445044%
Capitalized R&D asset: 12846600000
ROCI (R&D adjusted): 13.272845151280327%
Rosenberg metric: 0.6955063715627096
Free cash flow margin: 20.6960354820277%
Revenue growth: 9.95392532312111%
Rule of 40 score: 30.649960805148808
Market cap: 174120683357.88 (Large Cap ($10B-$200B))
P/E ratio: 22.580817450120605
Debt to equity: 6.306768306768307
Free cash flow (dilution adjusted): 7606000000
Operating income: 9080000000
Net income: 7711000000
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CMT (annual, report date 2025-12-31)
Altman Z-score: 4.141516447734517 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.334652292937998%
Earnings yield: 6.41651807615007%
Return on net tangible assets: 4.569751522036762%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.330415190839301%
Free cash flow margin: 0.04711502640632875%
Revenue growth: -9.451745828069502%
Rule of 40 score: -9.404630801663172
Market cap: 171694144.95000002 (Micro Cap ($50M-$300M))
P/E ratio: 15.33668110317106
Debt to equity: 0.20754120540427765
Free cash flow (dilution adjusted): 129000
Operating income: 14218000
Net income: 11195000
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EPR.OL (annual, report date 2025-12-31)
Altman Z-score: 3.2408108974640397 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 28.714660651906264%
Earnings yield: 0.7028966220655501%
Return on net tangible assets: 147.67241620995702%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.663369131176466%
Free cash flow margin: 9.085844905176591%
Revenue growth: 31.548662063286358%
Rule of 40 score: 40.63450696846295
Market cap: 15092022524.595419 (Large Cap ($10B-$200B))
P/E ratio: 18.66353199840648
Debt to equity: 1.2119145414524355
Free cash flow (dilution adjusted): 133257910.44776118
Operating income: 131234427.86069651
Net income: 80461393.03482586
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for GCT (annual, report date 2025-12-31)
Altman Z-score: 3.276199004655254 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 17.86271009050052%
Earnings yield: 10.075176126124004%
Return on net tangible assets: 29.477078817260566%
Capitalized R&D asset: 18687220
ROCI (R&D adjusted): 16.8075585968684%
Rosenberg metric: 1.575937085078133
Free cash flow margin: 13.786837243593869%
Revenue growth: 11.098220391682643%
Rule of 40 score: 24.88505763527651
Market cap: 1183598315.2 (Small Cap ($300M-$2B))
P/E ratio: 8.616008467518855
Debt to equity: 0.9668216690441932
Free cash flow (dilution adjusted): 177836000
Operating income: 145072000
Net income: 137372000
Long score: 13 | Short score: 0
Recommendation: Long
Stock screener scorecard for JBTM (annual, report date 2025-12-31)
Altman Z-score: 2.0576227363382964 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 28.99376905740422%
Earnings yield: 2.492995410163591%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.3295272893354646%
Free cash flow margin: 5.657943236269812%
Revenue growth: 121.34032634032634%
Rule of 40 score: 126.99826957659616
Market cap: 7833602315.4 (Mid Cap ($2B-$10B))
Debt to equity: 0.4215914691518437
Free cash flow (dilution adjusted): 214900000
Operating income: 218700000
Net income: -50500000
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MED.DE (annual, report date 2025-12-31)
Altman Z-score: 1.5318590062167445 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.500435818153962%
Earnings yield: 12.138187316972783%
Return on net tangible assets: 16.42144693382816%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.813486650352215%
Free cash flow margin: 6.502749776927981%
Revenue growth: 18.325791855203615%
Rule of 40 score: 24.828541632131596
Market cap: 173850000.00000003 (Micro Cap ($50M-$300M))
P/E ratio: 6.711911811540173
Debt to equity: 1.5656333648166634
Free cash flow (dilution adjusted): 60016555.29411765
Operating income: 61764705.88235294
Net income: 30472601.17647059
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SFQ.DE (annual, report date 2025-12-31)
Altman Z-score: 2.245269040812075 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 16.505372685310125%
Earnings yield: 11.692095088538302%
Return on net tangible assets: 121.87732363945378%
Capitalized R&D asset: 81210371.44607843
ROCI (R&D adjusted): 10.053847530332325%
Rosenberg metric: 0.5011756862946194
Free cash flow margin: 6.248054041712121%
Revenue growth: 4.372678143743024%
Rule of 40 score: 10.620732185455145
Market cap: 670927783.56 (Small Cap ($300M-$2B))
P/E ratio: 13.168615351822408
Debt to equity: 1.625727202136785
Free cash flow (dilution adjusted): 127487058.82352942
Operating income: 165495294.11764705
Net income: 59940000
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for TLK (annual, report date 2025-12-31)
Altman Z-score: 2.843068949885697 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 19.764006673154455%
Earnings yield: 12.29042415300377%
Return on net tangible assets: 34.64403936579317%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.020039722599154%
Free cash flow margin: 25.946218533207944%
Revenue growth: -5.8011640530873025%
Rule of 40 score: 20.145054480120642
Market cap: 320433814560852.3 (Mega Cap (>= $200B))
P/E ratio: 13.369234586150379
Debt to equity: 0.5027688155881981
Free cash flow (dilution adjusted): 2278652223.352684
Operating income: 2041953438.2668023
Net income: 1434436531.2107248
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for UNFI (annual, report date 2025-07-31)
Altman Z-score: 4.877884184382084 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.596439169139466%
Earnings yield: 1.7162511252853854%
Return on net tangible assets: -2.615062761506276%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.102944121770479%
Free cash flow margin: 0.5934718100890208%
Revenue growth: 2.1527992576554285%
Rule of 40 score: 2.7462710677444493
Market cap: 1672749029.6000001 (Small Cap ($300M-$2B))
Debt to equity: 2.220720720720721
Free cash flow (dilution adjusted): 196000000
Operating income: 105000000
Net income: -115000000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 1626.HK (annual, report date 2025-12-31)
Altman Z-score: 23.83639539494986 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.7351599318857667%
Earnings yield: 0.009864562622911606%
Return on net tangible assets: 8.07103946921343%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.618854471319087%
Free cash flow margin: -1.257022003699586%
Revenue growth: -12.706393942602151%
Rule of 40 score: -13.963415946301737
Market cap: 14183999488 (Large Cap ($10B-$200B))
P/E ratio: 374.41343791451334
Debt to equity: 0.385
Free cash flow (dilution adjusted): -1158142.857142857
Operating income: 1402000
Net income: 580857.1428571428
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1867.T (annual, report date 2026-03-31)
Altman Z-score: 2.6238161281978947 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 12.0061956820332%
Earnings yield: 0.10912299168310004%
Return on net tangible assets: 6.565786715133297%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.272325513581904%
Free cash flow margin: -8.220640041406858%
Revenue growth: 16.842460885486094%
Rule of 40 score: 8.621820844079236
Market cap: 18140891136 (Large Cap ($10B-$200B))
P/E ratio: 0.04791226816335986
Debt to equity: 0.2194
Free cash flow (dilution adjusted): -32550319.06906907
Operating income: 23280180.18018018
Net income: 15185641.891891891
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 1939.T (annual, report date 2026-03-31)
Altman Z-score: 4.146224893427271 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.152503949989699%
Earnings yield: 0.06577028894023947%
Return on net tangible assets: 10.746535665606542%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.140573506572219%
Free cash flow margin: 1.9809347598745073%
Revenue growth: -12.077787998904%
Rule of 40 score: -10.096853239029492
Market cap: 94195875840 (Large Cap ($10B-$200B))
P/E ratio: 0.07277927359894573
Debt to equity: 0.1108
Free cash flow (dilution adjusted): 12324824.824824825
Operating income: 55198948.94894895
Net income: 47122122.122122124
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 2486.HK (annual, report date 2025-12-31)
Altman Z-score: 5.332496300775879 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.083551356332555%
Earnings yield: 1.451683563972188%
Return on net tangible assets: 5.15982756946409%
Capitalized R&D asset: 4702532.682669045
ROCI (R&D adjusted): 6.169120259470081%
Rosenberg metric: 3.699893905152931
Free cash flow margin: 2.0975550803668983%
Revenue growth: 102.0476475818848%
Rule of 40 score: 104.1452026622517
Market cap: 430188864 (Small Cap ($300M-$2B))
P/E ratio: 4.352652488899276
Debt to equity: 0.122
Free cash flow (dilution adjusted): 6074714.285714285
Operating income: 5451142.857142857
Net income: 3531142.8571428573
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 2516.HK (annual, report date 2025-12-31)
Altman Z-score: 2.7046803145091634 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 12.257522050943864%
Earnings yield: 1.3006622319619736%
Return on net tangible assets: -4.562151020596514%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.279731198833728%
Free cash flow margin: 7.812669372613727%
Revenue growth: -30.330440111857676%
Rule of 40 score: -22.51777073924395
Market cap: 804960000 (Small Cap ($300M-$2B))
P/E ratio: 11.053984575835475
Debt to equity: 0.8134
Free cash flow (dilution adjusted): 22239857.14285714
Operating income: 10621142.857142856
Net income: 730714.2857142857
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3103.T (annual, report date 2026-03-31)
Altman Z-score: 1.6850238018266044 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 12.848304754481681%
Earnings yield: 0.1137490519642195%
Return on net tangible assets: 0.36617591543978617%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.114183354767592%
Free cash flow margin: 2.5547599166687753%
Revenue growth: -12.205260948348982%
Rule of 40 score: -9.650501031680207
Market cap: 48198615040 (Large Cap ($10B-$200B))
P/E ratio: 0.023124277925773155
Debt to equity: 1.0597
Free cash flow (dilution adjusted): 18950200.2002002
Operating income: 66003503.5035035
Net income: 113795045.04504505
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 4091.T (annual, report date 2026-03-31)
Altman Z-score: 2.2032340164987954 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.644497421049504%
Earnings yield: 0.03652258189234694%
Return on net tangible assets: 58.55504694652315%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.538916025092607%
Free cash flow margin: 12.021085442821512%
Revenue growth: -2.702174020485078%
Rule of 40 score: 9.318911422336434
Market cap: 2551671422976 (Mega Cap (>= $200B))
P/E ratio: 0.12082326654752483
Debt to equity: 0.6997
Free cash flow (dilution adjusted): 1022522522.5225224
Operating income: 1209515765.7657657
Net income: 800062562.5625626
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 5423.T (annual, report date 2026-03-31)
Altman Z-score: 3.6555542218565598 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.522471526972652%
Earnings yield: 0.04166030476603341%
Return on net tangible assets: 2.1633383956298022%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.012527548524982%
Free cash flow margin: -9.637255450493297%
Revenue growth: -23.203032617193735%
Rule of 40 score: -32.840288067687034
Market cap: 180006453248 (Large Cap ($10B-$200B))
P/E ratio: 0.08995487978870187
Debt to equity: 0.0012
Free cash flow (dilution adjusted): -161642892.8928929
Operating income: 45238988.98898899
Net income: 72303553.55355355
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 6082.T (annual, report date 2026-03-31)
Altman Z-score: 3.834115784586604 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 13.06233588524403%
Earnings yield: 0.11405555113747916%
Return on net tangible assets: 8.089856908177408%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.752973620680541%
Free cash flow margin: 1.3090164563447408%
Revenue growth: -4.634137111731026%
Rule of 40 score: -3.3251206553862853
Market cap: 9719747584 (Mid Cap ($2B-$10B))
P/E ratio: 0.08703824070155167
Debt to equity: 0.317
Free cash flow (dilution adjusted): 1951858.1081081082
Operating income: 5505173.923923924
Net income: 4380880.880880881
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7637.T (annual, report date 2026-03-31)
Altman Z-score: 3.717855257932226 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 13.369240562703922%
Earnings yield: 0.058275604083097815%
Return on net tangible assets: 10.567053331253609%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.21754075097038%
Free cash flow margin: 5.290438697118533%
Revenue growth: -3.9985639376204314%
Rule of 40 score: 1.2918747594981013
Market cap: 38505103360 (Large Cap ($10B-$200B))
P/E ratio: 0.08403432517657795
Debt to equity: 0
Free cash flow (dilution adjusted): 22543143.143143144
Operating income: 17969263.013013013
Net income: 13427733.983983984
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 9034.T (annual, report date 2026-03-31)
Altman Z-score: 2.4220352083615238 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 7.0614415515890165%
Earnings yield: 0.06723147972190675%
Return on net tangible assets: 3.8083979413237463%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.773751407940545%
Free cash flow margin: 5.046955755207487%
Revenue growth: -4.111894589357261%
Rule of 40 score: 0.9350611658502261
Market cap: 15168919552 (Large Cap ($10B-$200B))
P/E ratio: 0.06630330882057667
Debt to equity: 0.3425
Free cash flow (dilution adjusted): 5209547.047047047
Operating income: 12629379.379379379
Net income: 8463156.906906907
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ACQ.TO (quarterly, report date 2026-03-31)
Altman Z-score: 0.6593515975932764 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.33572712159861%
Earnings yield: 0.5087153967996945%
Return on net tangible assets: -3.6315160069791603%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.1722415471534702%
Free cash flow margin: -0.4881597705548149%
Revenue growth: 4.951237350742986%
Rule of 40 score: 4.463077580188171
Market cap: 548835968 (Small Cap ($300M-$2B))
P/E ratio: 39.95722341046083
Debt to equity: 4.3159
Free cash flow (dilution adjusted): -4175539.568345324
Operating income: 12483453.237410072
Net income: 3657553.956834533
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for ADVENZYMES.NS (quarterly, report date 2026-03-31)
Altman Z-score: 15.479247318885674 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.19637078333415%
Earnings yield: 0.019180971811707404%
Return on net tangible assets: 4.56113361989182%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.062055762023834%
Revenue growth: 12.518548382339109%
Rule of 40 score: 12.518548382339109
Market cap: 35535634432 (Large Cap ($10B-$200B))
P/E ratio: 0.17820600810830323
Debt to equity: 0.019
Operating income: 5620601.949978804
Net income: 4795676.133955066
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ADVENZYMES.NS (annual, report date 2026-03-31)
Altman Z-score: 16.023313894150213 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.19748325360366%
Earnings yield: 0.0694653816230841%
Return on net tangible assets: 13.320280525677147%
Capitalized R&D asset: 251156.03223964458
ROCI (R&D adjusted): 11.092692871499885%
Rosenberg metric: 18.318897838067034
Free cash flow margin: 13.3618363648567%
Revenue growth: 6.097525254896487%
Rule of 40 score: 19.45936161975319
Market cap: 35535634432 (Large Cap ($10B-$200B))
P/E ratio: 0.17820600810830323
Debt to equity: 0.019
Free cash flow (dilution adjusted): 10548855.447223399
Operating income: 20355447.223399747
Net income: 18398473.9296312
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ANG.AX (annual, report date 2025-06-30)
Altman Z-score: 2.3132871068911944 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 24.869070664325694%
Earnings yield: 17.643481133306565%
Return on net tangible assets: 23.30505610382588%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.466827126651957%
Free cash flow margin: -1.8322113468851355%
Revenue growth: 18.60260002353642%
Rule of 40 score: 16.770388676651287
Market cap: 87235520 (Micro Cap ($50M-$300M))
P/E ratio: 6.753812636165578
Debt to equity: 0.3668
Free cash flow (dilution adjusted): -4537908.496732026
Operating income: 21663398.692810457
Net income: 16984967.320261437
Long score: 9 | Short score: 3
Recommendation: Long
Stock screener scorecard for AXON (quarterly, report date 2026-03-31)
Altman Z-score: 7.484561840292543 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.5618957888687353%
Earnings yield: 0.07030744838470916%
Return on net tangible assets: 13.129486237495055%
Capitalized R&D asset: 377261900
ROCI (R&D adjusted): 0.5073435562276802%
Rosenberg metric: 0.0824091443177836
Free cash flow margin: -23.45255126371006%
Revenue growth: 1.333083978893569%
Rule of 40 score: -22.11946728481649
Market cap: 40489648128 (Large Cap ($10B-$200B))
P/E ratio: 172.6382113821138
Debt to equity: 0.5207
Free cash flow (dilution adjusted): -189343000
Operating income: 29243000
Net income: 169312000
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for CMI (quarterly, report date 2026-03-31)
Altman Z-score: 4.136781355084228 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.818956699624958%
Earnings yield: 1.022563543571089%
Return on net tangible assets: 9.736742662803879%
Capitalized R&D asset: 706350000
ROCI (R&D adjusted): 4.030523107465274%
Rosenberg metric: 0.8342857142857143
Free cash flow margin: 1.428911645629912%
Revenue growth: -1.6166822867853796%
Rule of 40 score: -0.1877706411554676
Market cap: 91714437120 (Large Cap ($10B-$200B))
P/E ratio: 27.832900882200313
Debt to equity: 0.6162
Free cash flow (dilution adjusted): 120000000
Operating income: 1000000000
Net income: 680000000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for COA.L (annual, report date 2025-12-31)
Altman Z-score: 1.5356587842829241 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 48.7660581473969%
Earnings yield: 16.247845975132154%
Return on net tangible assets: -24.544201011184317%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.667156189303139%
Free cash flow margin: 13.147655130043006%
Revenue growth: 10.51470172195923%
Rule of 40 score: 23.662356852002237
Market cap: 1451086464 (Small Cap ($300M-$2B))
P/E ratio: 0.2243243243243243
Debt to equity: 1.493
Free cash flow (dilution adjusted): 260270270.2702703
Operating income: 389864864.8648649
Net income: 163783783.7837838
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CONCORDBIO.NS (annual, report date 2026-03-31)
Altman Z-score: 38.37502038310451 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.579043243953757%
Earnings yield: 0.025578786536341595%
Return on net tangible assets: 11.924816704232082%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.75737419214291%
Free cash flow margin: 16.41218240676877%
Revenue growth: -19.60172881001697%
Rule of 40 score: -3.1895464032481975
Market cap: 130613338112 (Large Cap ($10B-$200B))
P/E ratio: 0.4343121619516958
Debt to equity: 0.0012
Free cash flow (dilution adjusted): 18199470.11445528
Operating income: 32305606.18906316
Net income: 27650052.988554474
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CONCORDBIO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 37.74873486036664 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 5.058895992218749%
Earnings yield: 0.008306056968211949%
Return on net tangible assets: 5.375756200179016%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.792079974826326%
Revenue growth: 11.683197100494743%
Rule of 40 score: 11.683197100494743
Market cap: 130613338112 (Large Cap ($10B-$200B))
P/E ratio: 0.4343121619516958
Debt to equity: 0.0012
Operating income: 10490419.66935142
Net income: 9409760.491733786
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DIOD (quarterly, report date 2026-03-31)
Altman Z-score: 6.017158385192189 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 1.2503886266640287%
Earnings yield: 0.528858084438572%
Return on net tangible assets: 1.1710441239772276%
Capitalized R&D asset: 81999630
ROCI (R&D adjusted): 0.8907339562789319%
Rosenberg metric: 0.1667557715674362
Free cash flow margin: 6.13120179940661%
Revenue growth: 3.546930624294521%
Rule of 40 score: 9.67813242370113
Market cap: 4002245888 (Mid Cap ($2B-$10B))
P/E ratio: 36.8972972972973
Debt to equity: 0.0538
Free cash flow (dilution adjusted): 24860000
Operating income: 19908000
Net income: 16102000
Long score: 8 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for GAP (quarterly, report date 2026-04-30)
Altman Z-score: 1.5398461182098573 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 5.327427271638932%
Earnings yield: 4.483988894095001%
Return on net tangible assets: 9.08344733242134%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.81810307492421%
Free cash flow margin: 1.0866456963111237%
Revenue growth: -17.445703493862133%
Rule of 40 score: -16.35905779755101
Market cap: 6843200000 (Mid Cap ($2B-$10B))
P/E ratio: 9.666666666666666
Debt to equity: 1.5436
Free cash flow (dilution adjusted): 38000000
Operating income: 445000000
Net income: 339000000
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GUFICBIO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.9041322167081143 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.999800951263391%
Earnings yield: 0.010142361506186423%
Return on net tangible assets: 4.4847415294430695%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.798108001576665%
Revenue growth: 3.5263876715733264%
Rule of 40 score: 3.5263876715733264
Market cap: 37992026112 (Large Cap ($10B-$200B))
P/E ratio: 0.45137423507068997
Debt to equity: 0.6087
Operating income: 4192623.993217465
Net income: 2320485.3751589656
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for GUFICBIO.NS (annual, report date 2026-03-31)
Altman Z-score: 4.618756844419915 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 15.229187242934877%
Earnings yield: 0.030893214343706586%
Return on net tangible assets: 9.694757727446394%
Capitalized R&D asset: 653605.6477106439
ROCI (R&D adjusted): 14.012243182755535%
Rosenberg metric: 5.142879811353388
Free cash flow margin: 1.4604347045878705%
Revenue growth: 4.386732806145675%
Rule of 40 score: 5.847167510733545
Market cap: 37992026112 (Large Cap ($10B-$200B))
P/E ratio: 0.45137423507068997
Debt to equity: 0.6087
Free cash flow (dilution adjusted): 1461064.0101738025
Operating income: 12770559.559135227
Net income: 6805288.257736329
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for HBLENGINE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 16.823478430847395 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 2.9652791156029106%
Earnings yield: 0.0034258284768348642%
Return on net tangible assets: 3.543307086614173%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5275257363002885%
Revenue growth: -34.2440285335327%
Rule of 40 score: -34.2440285335327
Market cap: 193648377856 (Large Cap ($10B-$200B))
P/E ratio: 0.22055765211285117
Debt to equity: 0.0302
Operating income: 6361805.849936414
Net income: 6756040.695209835
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for HBLENGINE.NS (annual, report date 2026-03-31)
Altman Z-score: 18.865311471263215 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 52.47699352410309%
Earnings yield: 0.06062740530818401%
Return on net tangible assets: 33.67429961036731%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 44.73000568409086%
Free cash flow margin: 17.806547718168964%
Revenue growth: 52.20153016895485%
Rule of 40 score: 70.00807788712382
Market cap: 193648377856 (Large Cap ($10B-$200B))
P/E ratio: 0.22055765211285117
Debt to equity: 0.0302
Free cash flow (dilution adjusted): 62327257.31242052
Operating income: 112585841.45824502
Net income: 86359686.30775753
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for INTT (quarterly, report date 2026-03-31)
Altman Z-score: 3.2568419137221767 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.9609737383601296%
Earnings yield: 0.9627588982282423%
Return on net tangible assets: 3.68498153382714%
Capitalized R&D asset: 4974590
ROCI (R&D adjusted): 1.5353234049086482%
Rosenberg metric: 0.21102819237147596
Free cash flow margin: -12.54205276515375%
Revenue growth: 3.2417281091950523%
Rule of 40 score: -9.300324655958697
Market cap: 173140976 (Micro Cap ($50M-$300M))
P/E ratio: 341.25
Debt to equity: 0.1677
Free cash flow (dilution adjusted): -4250000
Operating income: 1698000
Net income: 789000
Long score: 4 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for KRP (quarterly, report date 2026-03-31)
Altman Z-score: 2.3125660626970435 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 2.9535604723023927%
Earnings yield: 1.650204009001417%
Return on net tangible assets: 5.334136239461857%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.9287515789706173%
Free cash flow margin: 53.829165776163%
Revenue growth: 9.262862925196544%
Rule of 40 score: 63.092028701359546
Market cap: 1610152320 (Small Cap ($300M-$2B))
P/E ratio: 30.630434782608695
Debt to equity: 0.6113000000000001
Free cash flow (dilution adjusted): 45336000
Operating income: 34477000
Net income: 6942000
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for LTM.NS (annual, report date 2026-03-31)
Altman Z-score: 8.902130384606428 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 28.454754484563193%
Earnings yield: 0.06370180840827494%
Return on net tangible assets: 22.880972851280323%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.881615187342913%
Free cash flow margin: 9.075674346925847%
Revenue growth: 0.9075224688362339%
Rule of 40 score: 9.983196815762081
Market cap: 1243980890112 (Mega Cap (>= $200B))
P/E ratio: 0.2473281426844942
Debt to equity: 0.0958
Free cash flow (dilution adjusted): 406920305.2140738
Operating income: 693779143.7049598
Net income: 531803730.39423484
Long score: 11 | Short score: 1
Recommendation: Long
Stock screener scorecard for LTM.NS (quarterly, report date 2026-06-30)
Altman Z-score: 6.862146315107552 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.608516396388778%
Earnings yield: 0.017428964215783944%
Return on net tangible assets: 7.490398313047468%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.505743552288562%
Free cash flow margin: 8.89817367332874%
Revenue growth: 2.334831112203624%
Rule of 40 score: 11.233004785532364
Market cap: 1213059956736 (Mega Cap (>= $200B))
P/E ratio: 0.2116387633299819
Debt to equity: 0.0987
Free cash flow (dilution adjusted): 108967190.6319232
Operating income: 189819601.22375777
Net income: 154931954.84755775
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for MT.AS (quarterly, report date 2026-03-31)
Altman Z-score: 0.9192221549725718 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.5143592631324914%
Earnings yield: 1.5596248143807567%
Return on net tangible assets: 0.11869794391019176%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.987411487018096%
Free cash flow margin: -8.281037717538979%
Revenue growth: 0.8727985215861824%
Rule of 40 score: -7.408239195952796
Market cap: 43319439360 (Large Cap ($10B-$200B))
P/E ratio: 15.00085778006519
Debt to equity: 0.23920000000000002
Free cash flow (dilution adjusted): -1471264367.816092
Operating income: 865517241.3793104
Net income: 667816091.954023
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for OSWALPUMPS.NS (annual, report date 2026-03-31)
Altman Z-score: 7.840762126630466 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 30.05643265843741%
Earnings yield: 0.1412004552947345%
Return on net tangible assets: 15.247830472348037%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 28.6279167867997%
Free cash flow margin: -10.442557095586151%
Revenue growth: 30.840919008446193%
Rule of 40 score: 20.39836191286004
Market cap: 40944857088 (Large Cap ($10B-$200B))
P/E ratio: 0.08819126013979242
Debt to equity: 0.1411
Free cash flow (dilution adjusted): -22846015.260703687
Operating income: 52718842.72997033
Net income: 39876854.599406525
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for OSWALPUMPS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.526401062696089 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 6.87312319116412%
Earnings yield: 0.032288865911595056%
Return on net tangible assets: 5.767208731397252%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.546458823576804%
Revenue growth: -3.2187894294509944%
Rule of 40 score: -3.2187894294509944
Market cap: 40944857088 (Large Cap ($10B-$200B))
P/E ratio: 0.08819126013979242
Debt to equity: 0.1411
Operating income: 12055426.027977956
Net income: 9806485.799067402
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SCZ.V (quarterly, report date 2026-03-31)
Altman Z-score: 2.968432817567301 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 14.39001922970799%
Earnings yield: 3.0294961556206226%
Return on net tangible assets: 18.452006314551326%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.044933679570178%
Free cash flow margin: -1.2648103568600082%
Revenue growth: 22.28951039044234%
Rule of 40 score: 21.024700033582334
Market cap: 815190720 (Small Cap ($300M-$2B))
P/E ratio: 9.45417578980294
Debt to equity: 0.23370000000000002
Free cash flow (dilution adjusted): -1160431.654676259
Operating income: 24387769.784172665
Net income: 20482014.38848921
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SRM.NS (annual, report date 2026-03-31)
Altman Z-score: 3.0567247354951013 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 31.45184245655622%
Earnings yield: 0.13895690826003518%
Return on net tangible assets: -10.723729466038108%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 28.016156440914536%
Free cash flow margin: -9.280331303476796%
Revenue growth: 76.03853966633356%
Rule of 40 score: 66.75820836285676
Market cap: 11648672768 (Large Cap ($10B-$200B))
P/E ratio: 0.08372762132019995
Debt to equity: 0.32630000000000003
Free cash flow (dilution adjusted): -10086540.907164052
Operating income: 16077681.220856296
Net income: 11766013.141161509
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for SRM.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.198811187160419 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 14.275366209788551%
Earnings yield: 0.06306977899727124%
Return on net tangible assets: 17.103033974803605%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.715976608912857%
Revenue growth: 83.41035083249577%
Rule of 40 score: 83.41035083249577
Market cap: 11648672768 (Large Cap ($10B-$200B))
P/E ratio: 0.08372762132019995
Debt to equity: 0.32630000000000003
Operating income: 7297339.974565494
Net income: 5733149.63967783
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VIKRAMSOLR.NS (annual, report date 2026-03-31)
Altman Z-score: 3.4109298861852317 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 22.92843625957722%
Earnings yield: 0.11646127804320809%
Return on net tangible assets: -2.841974083782769%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 21.190135576898985%
Free cash flow margin: -2.2480707484885736%
Revenue growth: 27.16330285615693%
Rule of 40 score: 24.915232107668356
Market cap: 66238377984 (Large Cap ($10B-$200B))
P/E ratio: 0.13783467596787607
Debt to equity: 0.20370000000000002
Free cash flow (dilution adjusted): -11441076.727426875
Operating income: 84233573.54811361
Net income: 49853857.56676558
Long score: 10 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for VIKRAMSOLR.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.470552711022331 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 5.11760938798117%
Earnings yield: 0.025994067938290212%
Return on net tangible assets: 5.320440223808596%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.729622008811674%
Revenue growth: 24.973412504856064%
Rule of 40 score: 24.973412504856064
Market cap: 66238377984 (Large Cap ($10B-$200B))
P/E ratio: 0.13783467596787607
Debt to equity: 0.20370000000000002
Operating income: 18800869.012293346
Net income: 11702204.323866045
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ZJK (annual, report date 2025-12-31)
Altman Z-score: 15.618675373193577 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 22.16305164428805%
Earnings yield: 1.3390357667445754%
Return on net tangible assets: 13.808009278699359%
Capitalized R&D asset: 230451.98941927386
ROCI (R&D adjusted): 20.566207161305545%
Rosenberg metric: 21.867839459098523
Free cash flow margin: -1.812005674547878%
Revenue growth: 54.745124912127544%
Rule of 40 score: 52.93311923757967
Market cap: 115780040 (Micro Cap ($50M-$300M))
P/E ratio: 12.5
Debt to equity: 0.08839999999999999
Free cash flow (dilution adjusted): -145229.2857142857
Operating income: 1381218.2857142857
Net income: 1455005
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for ZTS (quarterly, report date 2026-03-31)
Altman Z-score: 3.5785587326919153 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.760151982901924%
Earnings yield: 2.113010711007791%
Return on net tangible assets: -121.03174603174602%
Capitalized R&D asset: 369430000
ROCI (R&D adjusted): 6.079984083655829%
Rosenberg metric: -0.271356783919598
Free cash flow margin: 11.75950486295314%
Revenue growth: -5.236698785085882%
Rule of 40 score: 6.522806077867258
Market cap: 31588839424 (Large Cap ($10B-$200B))
P/E ratio: 19.295081967213115
Debt to equity: 2.8624
Free cash flow (dilution adjusted): 266000000
Operating income: 822000000
Net income: 601000000
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2193.T (annual, report date 2025-12-31)
Altman Z-score: 7.1864753386809905 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.014371177912665%
Earnings yield: 0.05681316977753899%
Return on net tangible assets: 5.798386728454729%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.9640092721129807%
Revenue growth: -8.850450398277045%
Rule of 40 score: -8.850450398277045
Market cap: 10377922271.744633 (Large Cap ($10B-$200B))
P/E ratio: 13.997057428752626
Debt to equity: 0.05046309599369668
Operating income: 1690218.0167508472
Net income: 4740336.295633271
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 2461.T (annual, report date 2025-12-31)
Altman Z-score: 5.874225755531038 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 15.356385708935887%
Earnings yield: 0.09361835929530148%
Return on net tangible assets: 9.306195859919855%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.104497469985589%
Free cash flow margin: 27.038576050667235%
Revenue growth: 2.317116518860492%
Rule of 40 score: 29.355692569527726
Market cap: 32453947045.55045 (Large Cap ($10B-$200B))
P/E ratio: 24.81613597860066
Debt to equity: 0
Free cash flow (dilution adjusted): 12267981.58685506
Operating income: 12563288.792276708
Net income: 8361204.526564797
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 3678.T (annual, report date 2026-02-28)
Altman Z-score: 2.768444409460878 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 27.937158469945363%
Earnings yield: 0.07668454320400868%
Return on net tangible assets: 22.78796107716678%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.553672316384182%
Free cash flow margin: 1.7560831790080802%
Revenue growth: 2.5013310551078383%
Rule of 40 score: 4.2574142341159185
Market cap: 25060571925.999996 (Large Cap ($10B-$200B))
P/E ratio: 13.597705874118283
Debt to equity: 0.14053069719042666
Free cash flow (dilution adjusted): 12228923.392788399
Operating income: 15744899.26857436
Net income: 11824714.487360451
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 421A.T (annual, report date 2025-12-31)
Altman Z-score: 17.5335560512353 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 53.006111730735114%
Earnings yield: 0.03982363703952547%
Return on net tangible assets: 33.686373599441524%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 47.286723785448146%
Free cash flow margin: 46.66331725475251%
Revenue growth: 59.710290497010796%
Rule of 40 score: 106.3736077517633
Market cap: 25814728101.40376 (Large Cap ($10B-$200B))
P/E ratio: 22.380506517771305
Debt to equity: 0
Free cash flow (dilution adjusted): 11335931.2064446
Operating income: 11272872.578479636
Net income: 7374509.302474267
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 7803.T (annual, report date 2025-06-30)
Altman Z-score: 3.6119570451369802 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 18.664428419906287%
Earnings yield: 0.07998543219023335%
Return on net tangible assets: 17.743407984955052%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.679079861205338%
Free cash flow margin: 10.085042753505896%
Revenue growth: 35.0129506569867%
Rule of 40 score: 45.0979934104926
Market cap: 51384688244.439995 (Large Cap ($10B-$200B))
P/E ratio: 14.318903504032642
Debt to equity: 0.45939301610380406
Free cash flow (dilution adjusted): 39201051.75754221
Operating income: 33685489.89759202
Net income: 24831102.961527813
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ACQ.TO (annual, report date 2025-12-31)
Altman Z-score: 2.1621802259994958 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 17.509853010435513%
Earnings yield: 3.7821850354062505%
Return on net tangible assets: -23.242318964183738%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.718374533833137%
Free cash flow margin: -0.25423174955885236%
Revenue growth: -3.0501779977237575%
Rule of 40 score: -3.3044097472826097
Market cap: 544690339.6 (Small Cap ($300M-$2B))
P/E ratio: 30.363472858018838
Debt to equity: 3.9144397231397416
Free cash flow (dilution adjusted): -9086131.386861313
Operating income: 92811678.83211678
Net income: 13094160.583941605
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CMI (annual, report date 2025-12-31)
Altman Z-score: 4.595321725592461 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 26.09723160027009%
Earnings yield: 3.952208095902259%
Return on net tangible assets: 35.524001005277704%
Capitalized R&D asset: 2871210000
ROCI (R&D adjusted): 13.9726659721919%
Rosenberg metric: 0.05263157894736842
Free cash flow margin: 7.086427086427087%
Revenue growth: -1.2667878716790804%
Rule of 40 score: 5.8196392147480065
Market cap: 69981155329.05 (Large Cap ($10B-$200B))
P/E ratio: 23.66626828848495
Debt to equity: 0.6051610978520287
Free cash flow (dilution adjusted): 2386000000
Operating income: 3865000000
Net income: 2957000000
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for DIOD (annual, report date 2025-12-31)
Altman Z-score: 4.774797284100998 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.3836772940145674%
Earnings yield: 0.9677135975451227%
Return on net tangible assets: 8.582555848823906%
Capitalized R&D asset: 296495610
ROCI (R&D adjusted): 2.3203325865543323%
Rosenberg metric: 0.19823798405084633
Free cash flow margin: 7.516903688279862%
Revenue growth: 13.038699737628898%
Rule of 40 score: 20.55560342590876
Market cap: 2266913175.56 (Mid Cap ($2B-$10B))
P/E ratio: 32.77306889634235
Debt to equity: 0.049323439996409424
Free cash flow (dilution adjusted): 111406000
Operating income: 36428000
Net income: 69170000
Long score: 9 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GAP (annual, report date 2026-01-31)
Altman Z-score: 2.8162238667020283 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 13.2312804082117%
Earnings yield: 11.235163184080733%
Return on net tangible assets: 23.81895332390382%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.948135447921132%
Free cash flow margin: 4.3017050631263825%
Revenue growth: 1.8560254540633698%
Rule of 40 score: 6.157730517189752
Market cap: 9910220025.49 (Mid Cap ($2B-$10B))
P/E ratio: 12.144877482218137
Debt to equity: 1.4761904761904763
Free cash flow (dilution adjusted): 661000000
Operating income: 1115000000
Net income: 816000000
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for KRP (annual, report date 2025-12-31)
Altman Z-score: 2.110255695777821 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 10.004889003057698%
Earnings yield: 5.778992709308034%
Return on net tangible assets: 0.15521879769140998%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.903871629785604%
Free cash flow margin: 2.065649486074116%
Revenue growth: 3.568945315014872%
Rule of 40 score: 5.634594801088989
Market cap: 1100959310.88 (Small Cap ($300M-$2B))
P/E ratio: 11.048151156335612
Debt to equity: 0.5767383206580785
Free cash flow (dilution adjusted): 6646000
Operating income: 120738000
Net income: 99651000
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for CBQS.L (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.336940846099528%
Capitalized R&D asset: 0
Free cash flow margin: 178.5265890435819%
Revenue growth: 9.704077813471788%
Rule of 40 score: 188.2306668570537
Market cap: 12141761.25 (Nano Cap (< $50M))
P/E ratio: 0.005506607537424986
Debt to equity: 1.525550029798074
Free cash flow (dilution adjusted): 11445916216.216217
Net income: 2979654054.0540543
Long score: 2 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for DIS.L (quarterly, report date 2024-09-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 0 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral